SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-23-016195
Filing Date
2023-10-02
Accepted
2023-10-02 16:30:23
Documents
12
Period of Report
2023-09-27
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K agrx-20230927x8k.htm   iXBRL 8-K 39865
  Complete submission text file 0001558370-23-016195.txt   161404

Data Files

Seq Description Document Type Size
2 EX-101.SCH agrx-20230927.xsd EX-101.SCH 3160
3 EX-101.LAB agrx-20230927_lab.xml EX-101.LAB 15927
4 EX-101.PRE agrx-20230927_pre.xml EX-101.PRE 10131
6 EXTRACTED XBRL INSTANCE DOCUMENT agrx-20230927x8k_htm.xml XML 4858
Mailing Address 500 COLLEGE ROAD EAST SUITE 310 PRINCETON NJ 08540-6635
Business Address 500 COLLEGE ROAD EAST SUITE 310 PRINCETON NJ 08540-6635 609-683-1880
AGILE THERAPEUTICS INC (Filer) CIK: 0001261249 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36464 | Film No.: 231300114
SIC: 2834 Pharmaceutical Preparations